Range Low Price High Price Comment
30 days $4.61 $7.24 Tuesday, 30th Apr 2024 AFMD stock ended at $5.35. This is 2.55% less than the trading day before Monday, 29th Apr 2024. During the day the stock fluctuated 7.65% from a day low at $5.10 to a day high of $5.49.
90 days $4.25 $7.24
52 weeks $2.24 $11.10

Historical Affimed N.V. prices

Date Open High Low Close Volume
Feb 02, 2016 $33.00 $33.00 $33.00 $33.00 19 040
Feb 01, 2016 $34.50 $34.50 $34.50 $34.50 16 160
Jan 29, 2016 $33.20 $33.20 $33.20 $33.20 43 150
Jan 28, 2016 $31.70 $31.70 $31.70 $31.70 37 610
Jan 27, 2016 $34.40 $34.40 $34.40 $34.40 41 640
Jan 26, 2016 $38.60 $38.60 $38.60 $38.60 55 990
Jan 25, 2016 $40.00 $40.00 $40.00 $40.00 301 270
Jan 22, 2016 $37.00 $37.00 $37.00 $37.00 26 190
Jan 21, 2016 $34.70 $34.70 $34.70 $34.70 39 140
Jan 20, 2016 $33.40 $33.40 $33.40 $33.40 47 480
Jan 19, 2016 $32.10 $32.10 $32.10 $32.10 66 180
Jan 15, 2016 $36.40 $36.40 $36.40 $36.40 53 580
Jan 14, 2016 $38.20 $38.20 $38.20 $38.20 54 240
Jan 13, 2016 $38.40 $38.40 $38.40 $38.40 41 200
Jan 12, 2016 $44.20 $44.20 $44.20 $44.20 42 540
Jan 11, 2016 $44.90 $44.90 $44.90 $44.90 53 240
Jan 08, 2016 $50.50 $50.50 $50.50 $50.50 22 930
Jan 07, 2016 $54.70 $54.70 $54.70 $54.70 48 120
Jan 06, 2016 $57.70 $57.70 $57.70 $57.70 26 910
Jan 05, 2016 $62.50 $62.50 $62.50 $62.50 41 030
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT